« Back
Home /
Dolutegravir

Dolutegravir

Item no.	M3484-5mg
Manufacturer	AbMole
CASRN	1051375-16-6
Amount	5mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Pancreatic Cancer
Type	Inhibitors
Specific against	other
Purity	0,9968
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	GSK1349572
Available
Target Information	Integrase
Molecular Weight	419, 38
Solubility	DMSO 60 mg/mL
Bioactivity information	Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM, modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M3484-5mg-safety-datasheet.pdf